期刊
CLINICS IN CHEST MEDICINE
卷 37, 期 1, 页码 147-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2015.11.003
关键词
Chronic obstructive pulmonary disease; Cystic fibrosis transmembrane conductance regulator; Chronic bronchitis; Mucociliary clearance
资金
- NIH [R01 HL105487, P30 DK072482, 5UL1 RR025777]
- Cystic Fibrosis Foundation [CLANCY09Y0, R464-CF]
- American Lung Association [RG-305752]
- Flight Attendants Medical Research Association [YFA130008]
Chronic obstructive pulmonary disease (COPD) is a major public health problem. No therapies alter the natural history of the disease. Chronic bronchitis is perhaps the most clinically troublesome phenotype. Emerging data strongly suggest that cigarette smoke and its components can lead to acquired cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. Findings in vitro, in animal models, and in smokers with and without COPD also show acquired CFTR dysfunction, which is associated with chronic bronchitis. This abnormality is also present in extrapulmonary organs, suggesting that CFTR dysfunction may contribute to smoking-related systemic diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据